Overview

Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The present study examines the short- and long-term clinical efficacy of cognitive-behavior therapy and pharmacological treatment in patients suffering from late-life primary insomnia. 46 subjects suffering from chronic primary insomnia were randomized into either cognitive-behavior therapy (CBT, n=18), hypnotics (7.5 mg Zopiclone, n=16), or placebo treatment (n=12). All active treatments lasted 6 weeks with follow-ups conducted at 6 months. Ambulant clinical polysomnography (PSG) and sleep diaries were used on all three assessment points.
Phase:
Phase 4
Details
Lead Sponsor:
University of Bergen
Treatments:
Zopiclone